Apo-Loperamide
Brand names,
Apo-Loperamide
Analogs
Apo-Loperamide
Brand Names Mixture
Apo-Loperamide
Chemical_Formula
C29H33ClN2O2
Apo-Loperamide
RX_link
http://www.rxlist.com/cgi/generic3/loperamide.htm
Apo-Loperamide
fda sheet
Apo-Loperamide
msds (material safety sheet)
Apo-Loperamide
Synthesis Reference
No information avaliable
Apo-Loperamide
Molecular Weight
477.037 g/mol
Apo-Loperamide
Melting Point
228 oC
Apo-Loperamide
H2O Solubility
Slight
Apo-Loperamide
State
Solid
Apo-Loperamide
LogP
6.249
Apo-Loperamide
Dosage Forms
Capsule; Liquid; Tablet
Apo-Loperamide
Indication
For the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease or gastroenteritis. Also used for reducing the volume of discharge from ileostomies.
Apo-Loperamide
Pharmacology
Loperamide is a synthetic anti-diarrheal indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease. Loperamide is also indicated for reducing the volume of discharge from ileostomies. In man, Loperamide prolongs the transit time of the intestinal contents. It reduces the daily fecal volume, increases the viscosity and bulk density, and diminishes the loss of fluid and electrolytes. Tolerance to the antidiarrheal effect has not been observed. Loperamide is an opioid receptor agonist and acts on the mu opioid receptors in the myenteric plexus large intestines; it does not affect the central nervous system like other opioids. It works specifically by decreasing the activity of the myenteric plexus which decreases the motility of the circular and longitudinal smooth muscles of the intestinal wall. This increases the amount of time substances stay in the intestine, allowing for more water to be absorbed out of the fecal matter. Loperamide also decreases colonic mass movements and suppresses the gastrocolic reflex.
Apo-Loperamide
Absorption
Not significantly absorbed from the gut
Apo-Loperamide
side effects and Toxicity
Oral, mouse: LD50 = 105 mg/kg. Symptoms of overdose include constipation, drowsiness, lethargy, and nausea.
Apo-Loperamide
Patient Information
Patients should be advised to check with their physician if their diarrhea does not improve after a couple of days
or if they note blood in their stools or develop a fever.
Apo-Loperamide
Organisms Affected
Humans and other mammals